This chemical is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting neurological and psychiatric disorders. Its structure, featuring a Boc-protected piperazine ring and a phenylacetic acid moiety, makes it valuable for creating molecules with specific binding properties to receptors in the central nervous system. Additionally, it is utilized in peptide coupling reactions and as a building block in medicinal chemistry for designing drugs with improved bioavailability and efficacy. Its role in protecting groups and facilitating complex organic transformations further highlights its importance in drug discovery and development processes.